Radiotherapy dose-fractionations and outcomes in cancer patients by Ramroth, J

Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: Modelling life expectancy using radiation dosimetry by Jones, DA, Candio, P, Shakir, R, Ntentas, G, Ramroth, J, Gray, AM, Cutter, DJ

Individualised estimation of quality-adjusted survival benefit and cost-effectiveness of proton beam therapy in intermediate-stage Hodgkin lymphoma by Jones, DA, Candio, P, Shakir, R, Ramroth, J, Wolstenholme, J, Gray, AM, Cutter, DJ, Ntentas, G

Predicted risks of cardiovascular disease following chemotherapy and radiotherapy in the UK NCRI RAPID trial of positron emission tomography–directed therapy for early-stage Hodgki... by Cutter, DJ, Ramroth, J, Diez, P, Buckle, A, Ntentas, G, Popova, B, Clifton-Hadley, L, Hoskin, PJ, Darby, SC, Radford, J, Illidge, T